Lipoprotein (a) Infographics

This infographic offers a comprehensive overview of lipoprotein(a) [Lp(a)] in atherosclerotic cardiovascular disease (ASCVD), emphasizing the integration of Lp(a) screening in clinical practice and emerging Lp(a)-lowering therapies. It examines global clinical guidelines, factors affecting Lp(a) levels, and global variations, while highlighting challenges and barriers in measurement and management. By targeting alternative lipid factors, the infographic underscores the potential to address the residual risk of ASCVD, providing valuable insights into the screening and therapeutic management of elevated Lp(a).

First published: September 15, 2025  

In this infographic, we look at current treatment strategies and future innovations.

First published: November 8, 2023  

This infographic summarizes the key take home messages of the World Heart Federation’s Cholesterol Roadmap.

First published: March 3, 2023  

Check out and download our latest infographic based on the consensus statement from the European Atherosclerotic Society (EAS) Congress, highlighting the role of Lp(a) in ASCVD and Aortic Stenosis.

First published: September 30, 2022  

Novel pharmacological interventions targeting lipids can lower the incidence of dyslipidaemia triggered cardiovascular events. Check out and download our latest infographic providing insights into evolution of lipid-lowering therapeutics and status of novel therapeutics highlighting their development, safety, and efficacy.

First published: August 8, 2022  

To mark the first Lipoprotein (a) awareness day on March 24, 2022, check out and download our latest infographic that highlights the role of Lp (a) in Familial Hypercholesterolaemia and ASCVD.

First published: March 24, 2022  

This infographic summarizes the key takeaway messages from the recently published National Lipid Association (NLA) Scientific Statement on Lipid Measurements in the Management of Cardiovascular Diseases.

First published: October 21, 2021